What is claimed is:
1. A pharmaceutical composition, comprising (a) granisetron or a pharmaceutically salt, (b) at least one aqueous vehicle polymer that is selected from a group consisting of rheology-changeable polymer, bioadhesive polymer and the combination thereof.
This invention relates to a pharmaceutical composition, particularly a bioadhesive composition comprising granisetron or a pharmaceutically salt thereof, as the active ingredient for intranasal administration with enhanced and prolonged granisetron absorption as well as reduced nasal stinging and dripping. The composition is suitable for rapid and sustained prevention and/or relief...